paclitaxel has been researched along with Thoracic Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Gao, S; He, J; Huang, J; Jiang, Y; Liu, Y; Lyu, X; Mao, Y; Shao, K; Wang, J | 1 |
| Choi, M; Gadgeel, SM; Heilbrun, LK; Jiang, PQ; Smith, DW | 1 |
| Hashimoto, K; Inoue, M; Kitajima, T; Koike, Y; Komada, Y; Kusunoki, M; Matsushita, K; Otake, K; Tanaka, K; Uchida, K; Ueeda, M | 1 |
| Chen, EC; Chen, XM; Hao, CG; Ma, JB; Qin, G; Song, YP; Wei, L | 1 |
| Aruga, E; Karasawa, K; Kimura, T; Kohno, M; Maebayashi, K; Mitsuhashi, N; Muramatsu, H; Nasu, S; Saitou, M; Seki, K; Suzuki, K; Ueda, M; Umeda, M | 1 |
| Chen, Y; Johnstone, D; Keng, PC; Lee, YJ; Li, J; Okunieff, P; Pandya, K; Smudzin, T | 1 |
| Abrams, DI; Cheng, J; Dhruva, A; Kwong, M; Luce, JA | 1 |
| Blackstock, AW; Bogart, JA; Green, M; Gu, L; Masters, GA; Miller, AA; Munley, M; Rosenman, J; Sleeper, A; Socinski, MA; Ungaro, P; Vokes, EE; Wang, X | 1 |
2 trial(s) available for paclitaxel and Thoracic Neoplasms
| Article | Year |
|---|---|
Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines.
Topics: Apoptosis; Cell Cycle; Combined Modality Therapy; Dose-Response Relationship, Radiation; G2 Phase; Humans; Maximum Tolerated Dose; Mitosis; Paclitaxel; Radiation-Sensitizing Agents; Thoracic Neoplasms; Time Factors; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2003 |
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Placebos; Prognosis; Radiography; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Survival Rate; Thoracic Neoplasms | 2008 |
6 other study(ies) available for paclitaxel and Thoracic Neoplasms
| Article | Year |
|---|---|
Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Thoracic Neoplasms | 2014 |
Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Neoplasms; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thoracic Neoplasms; Treatment Outcome; Urogenital Neoplasms | 2008 |
HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma.
Topics: Abdominal Neoplasms; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Line, Tumor; Child, Preschool; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Infant; Infant, Newborn; Japan; Mad2 Proteins; Male; Neuroblastoma; Paclitaxel; Prognosis; Repressor Proteins; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Thoracic Neoplasms | 2011 |
Moderately hypofractionated conformal radiation treatment of thoracic esophageal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Radiation Injuries; Radiotherapy, Conformal; Survival Rate; Thoracic Neoplasms | 2012 |
[A case of recurrent breast cancer with chronic renal failure treated on an outpatient basis].
Topics: Ambulatory Care; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Kidney Failure, Chronic; Lung Neoplasms; Middle Aged; Paclitaxel; Radiotherapy Dosage; Renal Dialysis; Taxoids; Thoracic Neoplasms | 2002 |
Contrasts, conflicts, and change: A case in cultural oncology.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Attitude to Health; Carboplatin; Cultural Characteristics; Erlotinib Hydrochloride; Family Relations; Female; Humans; Middle Aged; Paclitaxel; Physician-Patient Relations; Quinazolines; Thoracic Neoplasms | 2006 |